Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice

被引:49
作者
Ikeda, Kohei [1 ,2 ]
Marutani, Eizo [1 ,2 ]
Hirai, Shuichi [1 ,2 ]
Wood, Mark E. [3 ]
Whiteman, Matthew [4 ]
Ichinose, Fumito [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Exeter, Dept Biosci, Coll Life & Environm Sci, Exeter EX4 4QJ, Devon, England
[4] Univ Exeter, Sch Med, Exeter, Devon, England
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2015年 / 49卷
基金
美国国家卫生研究院;
关键词
Cardiac arrest; Resuscitation; Hydrogen sulfide; Mitochondria; CARDIOPULMONARY-RESUSCITATION; ISCHEMIA-REPERFUSION; PROTECTS; SURVIVAL; BRAIN; PRESERVATION; HYPOTHERMIA; INJURY; MODEL; DEATH;
D O I
10.1016/j.niox.2015.05.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Aims: Mitochondria-targeted hydrogen sulfide donor AP39, [(10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5yl) phenoxy)decyl) triphenylphosphonium bromide], exhibits cytoprotective effects against oxidative stress in vitro. We examined whether or not AP39 improves the neurological function and long term survival in mice subjected to cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). Methods: Adult C57BL/6 male mice were subjected to 8 min of CA and subsequent CPR. We examined the effects of AP39 (10, 100, 1000 nmol kg(-1)) or vehicle administered intravenously at 2 min before CPR (Experiment 1). Systemic oxidative stress levels, mitochondrial permeability transition, and histological brain injury were assessed. We also examined the effects of AP39 (10, 1000 nmol kg(-1)) or vehicle administered intravenously at 1 min after return of spontaneous circulation (ROSC) (Experiment 2). ROSC was defined as the return of sinus rhythm with a mean arterial pressure >40 mm Hg lasting at least 10 seconds. Results: Vehicle treated mice subjected to CA/CPR had poor neurological function and 10-day survival rate (Experiment 1; 15%, Experiment 2; 23%). Administration of AP39 (100 and 1000 nmol kg-1) 2 min before CPR significantly improved the neurological function and 10-day survival rate (54% and 62%, respectively) after CA/CPR. Administration of AP39 before CPR attenuated mitochondria] permeability transition pore opening, reactive oxygen species generation, and neuronal degeneration after CA/CPR. Administration of AP39 1 min after ROSC at 10 nmol kg(-1), but not at 1000 nmol kg(-1), significantly improved the neurological function and 10-day survival rate (69%) after CA/CPR. Conclusion: The current results suggest that administration of mitochondria-targeted sulfide donor AP39 at the time of CPR or after ROSC improves the neurological function and long term survival rates after CA/CPR by maintaining mitochondrial integrity and reducing oxidative stress. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 34 条
[1]
Intra-arrest cooling improves outcomes in a murine cardiac arrest model [J].
Abella, BS ;
Zhao, DH ;
Alvarado, J ;
Hamann, K ;
Vanden Hoek, TL ;
Becker, LB .
CIRCULATION, 2004, 109 (22) :2786-2791
[2]
Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies [J].
Berdowski, Jocelyn ;
Berg, Robert A. ;
Tijssen, Jan G. P. ;
Koster, Rudolph W. .
RESUSCITATION, 2010, 81 (11) :1479-1487
[3]
Bos E.M., 2014, BRIT J PHARMACOL, V172, P1479
[4]
HYDROGEN SULFIDE DOES NOT INCREASE RESUSCITABILITY IN A PORCINE MODEL OF PROLONGED CARDIAC ARREST [J].
Derwall, Matthias ;
Westerkamp, Maren ;
Loewer, Celine ;
Deike-Glindemann, Jan ;
Schnorrenberger, Nora Katharina ;
Coburn, Mark ;
Nolte, Kay Wilhelm ;
Gaisa, Nadine ;
Weis, Joachim ;
Siepmann, Katharina ;
Haeusler, Martin ;
Rossaint, Rolf ;
Fries, Michael .
SHOCK, 2010, 34 (02) :190-195
[5]
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function [J].
Elrod, John W. ;
Calvert, John W. ;
Morrison, Joanna ;
Doeller, Jeannette E. ;
Kraus, David W. ;
Tao, Ling ;
Jiao, Xiangying ;
Scalia, Rosario ;
Kiss, Levente ;
Szabo, Csaba ;
Kimura, Hideo ;
Chow, Chi-Wing ;
Lefer, David J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15560-15565
[6]
Part 1: Executive Summary 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [J].
Field, John M. ;
Hazinski, Mary Fran ;
Sayre, Michael R. ;
Chameides, Leon ;
Schexnayder, Stephen M. ;
Hemphill, Robin ;
Samson, Ricardo A. ;
Kattwinkel, John ;
Berg, Robert A. ;
Bhanji, Farhan ;
Cave, Diana M. ;
Jauch, Edward C. ;
Kudenchuk, Peter J. ;
Neumar, Robert W. ;
Peberdy, Mary Ann ;
Perlman, Jeffrey M. ;
Sinz, Elizabeth ;
Travers, Andrew H. ;
Berg, Marc D. ;
Billi, John E. ;
Eigel, Brian ;
Hickey, Robert W. ;
Kleinman, Monica E. ;
Link, Mark S. ;
Morrison, Laurie J. ;
O'Connor, Robert E. ;
Shuster, Michael ;
Callaway, Clifton W. ;
Cucchiara, Brett ;
Ferguson, Jeffrey D. ;
Rea, Thomas D. ;
Vanden Hoek, Terry L. .
CIRCULATION, 2010, 122 (18) :S640-S656
[7]
Geng Y., 2014, J CEREB BLOOD FLOW M, V35, P494
[8]
What is the mitochondrial permeability transition pore? [J].
Halestrap, Andrew P. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (06) :821-831
[9]
Early mitochondrial dysfunction in electron transfer activity and reactive oxygen species generation after cardiac arrest [J].
Han, Fei ;
Da, Tong ;
Riobo, Natalia A. ;
Becker, Lance B. .
CRITICAL CARE MEDICINE, 2008, 36 (11) :S447-S453
[10]
Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Goteborg [J].
Herlitz, J ;
Andersson, E ;
Bång, A ;
Engdahl, J ;
Holmberg, M ;
Lindqvist, J ;
Karlson, BW ;
Waagstein, L .
EUROPEAN HEART JOURNAL, 2000, 21 (15) :1251-1258